Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Sanara MedTech (SMTI) Change in Receivables (2016 - 2025)

Historic Change in Receivables for Sanara MedTech (SMTI) over the last 15 years, with Q3 2025 value amounting to $270045.0.

  • Sanara MedTech's Change in Receivables fell 5844.69% to $270045.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $1.9 million, marking a year-over-year decrease of 5067.61%. This contributed to the annual value of $4.5 million for FY2024, which is 14748.73% up from last year.
  • Per Sanara MedTech's latest filing, its Change in Receivables stood at $270045.0 for Q3 2025, which was down 5844.69% from $243198.0 recorded in Q2 2025.
  • Sanara MedTech's Change in Receivables' 5-year high stood at $1.7 million during Q4 2024, with a 5-year trough of -$415895.0 in Q3 2022.
  • In the last 5 years, Sanara MedTech's Change in Receivables had a median value of $523577.0 in 2021 and averaged $495844.9.
  • Over the last 5 years, Sanara MedTech's Change in Receivables had its largest YoY gain of 170467.06% in 2022, and its largest YoY loss of 28584.54% in 2022.
  • Sanara MedTech's Change in Receivables (Quarter) stood at $523577.0 in 2021, then soared by 185.59% to $1.5 million in 2022, then plummeted by 31.28% to $1.0 million in 2023, then surged by 68.53% to $1.7 million in 2024, then crashed by 84.41% to $270045.0 in 2025.
  • Its Change in Receivables was $270045.0 in Q3 2025, compared to $243198.0 in Q2 2025 and -$368284.0 in Q1 2025.